Company intelligence / Profile preview

Nortia Capital Partners

Paris, France

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Nortia Capital Partners is a French private equity and venture capital firm that operates as part of the DLPK Group. The firm specializes in wealth management and financial services but maintains a significant investment focus on the healthcare and life sciences sectors. Nortia Capital Partners provides strategic capital and advisory services to growth-stage companies, helping them scale their operations and navigate complex regulatory environments. While primarily an investment entity rather than a drug developer, the firm plays a crucial role in the European biotech ecosystem by funding innovative healthcare solutions and medical technologies.

Industry: Investors

Beyond the preview

Go deeper on Nortia Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nortia Capital Partners.

Explore the full profile